LSE Equity Snapshot
HIK Weekly Equity Report
Hikma Pharmaceuticals PLC
What the company does
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, …
What the weekly tape is saying
HIK closed the latest completed week at 1,480 GBP. The 4-week return is 2.8% and the 12-week return is 18.0%. Trend Signal is inactive, Market Dynamics is 0.82. Setup signature: Risk-first tape with a 35/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1,453 GBP
- Vs Trend Line
- 1.8%
- Fair Value
- 1,843 GBP
- Vs Fair Value
- -19.7%
- 52W High
- 2,129 GBP
- 52W Low
- 1,187 GBP
- Drawdown
- -30.5%
- Range Position
- 31.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 0
- 52W Active Breadth
- 0.0%
- Sector Scope
- GB Healthcare
- Sector Rank
- 15 of 78
- Sector Percentile
- 81.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
GB Healthcare
- Tracked Peers
- 78
- 4W Rank
- 24 of 78
- Avg 1W
- -2.0%
- Avg 4W
- -0.2%
- Trend Breadth
- 38.5%
- Positive MD
- 55.1%
GB Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 9
- 4W Rank
- 1 of 9
- Avg 1W
- -1.8%
- Avg 4W
- -7.4%
- Trend Breadth
- 22.2%
- Positive RS
- 22.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.82
- 4W MD Change
- 252.4%
- Relative Strength
- -14.63
- 4W RS Change
- 20.8%
- Expectation
- Undecided
- Probability
- 51.33%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.3M
- 13W Average
- 4.9M
- 52W Average
- 4.2M
- Vs 13W
- 0.5x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 1.6%
- 52W Volatility
- 4.7%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 2.6% / -3.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- LSE
- Country
- GB
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- GBP
- Market Cap
- 3.1B
Opportunity signals
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 1,480 GBP | 0.6% | 1,453 GBP | 1,843 GBP | 0.82 | -14.63 | 2.3M | Off |
| 5 Jun 2026 | 1,471 GBP | -0.3% | 1,457 GBP | 1,846 GBP | 0.73 | -15.27 | 5.8M | Off |
| 29 May 2026 | 1,476 GBP | 1.2% | 1,460 GBP | 1,848 GBP | 0.55 | -16.27 | 4.2M | Off |
| 22 May 2026 | 1,459 GBP | 1.3% | 1,472 GBP | 1,850 GBP | 0.41 | -18.63 | 4.2M | Off |
| 15 May 2026 | 1,440 GBP | 1.6% | 1,482 GBP | 1,853 GBP | 0.23 | -18.46 | 3.3M | Off |
| 8 May 2026 | 1,418 GBP | 0.7% | 1,493 GBP | 1,855 GBP | 0.03 | -20.88 | 3.0M | Off |
| 1 May 2026 | 1,408 GBP | 1.7% | 1,507 GBP | 1,858 GBP | -0.19 | -23.21 | 3.8M | Off |
| 24 Apr 2026 | 1,385 GBP | 0.4% | 1,521 GBP | 1,861 GBP | -0.40 | -25.36 | 4.2M | Off |
| 17 Apr 2026 | 1,379 GBP | 4.3% | 1,530 GBP | 1,864 GBP | -0.63 | -28.41 | 3.6M | Off |
| 10 Apr 2026 | 1,322 GBP | 1.1% | 1,538 GBP | 1,867 GBP | -0.73 | -31.65 | 4.4M | Off |
| 3 Apr 2026 | 1,308 GBP | 5.2% | 1,548 GBP | 1,870 GBP | -0.87 | -32.06 | 6.1M | Off |
| 27 Mar 2026 | 1,243 GBP | -0.9% | 1,562 GBP | 1,873 GBP | -0.94 | -33.15 | 6.6M | Off |
| 20 Mar 2026 | 1,254 GBP | 1.2% | 1,580 GBP | 1,875 GBP | -0.74 | -32.93 | 12.2M | Off |
| 13 Mar 2026 | 1,240 GBP | 2.6% | 1,599 GBP | 1,878 GBP | -0.28 | -36.60 | 5.5M | Off |